Skip to main content
  • 691 Accesses

Abstrait

Dans la famille des Herpesviridae, huit virus sont strictement humains et sont la cause d’infections dont les manifestations cliniques sont différentes, avec des présentations dermatologiques souvent similaires. On distingue trois sous-familles : les alpha-, les bêta- et les gamma-Herpesviridae (tableau 31.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Nguyen HO, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 2005; 352:450–458.

    Article  PubMed  CAS  Google Scholar 

  2. Vazquez M, La Russa PS, Gershon AA et al. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med 2001; 344:955–960.

    Article  PubMed  CAS  Google Scholar 

  3. Quirk M. Varicella vaccination reduces risk of herpes zoster. Lancet Infect Dis 2002; 2:454.

    Article  PubMed  Google Scholar 

  4. Fillet AM, Sadzot-Devaux C, Rentler B. Virus varicelle-zona. In: Huraux JM, Nicolas JC, Agut H, Peigue-Lafeuille H, éd. Virologie médicale. Paris: Estem; 2003. p. 179–193.

    Google Scholar 

  5. Bourgault-Villada I. Réponses immunitaires aux virus: I. Réponse immunitaire cellulaire. In: Chosidow O, ed. Virus et peau. Paris: Esterm; 1994: 17–20.

    Google Scholar 

  6. Straus SE, Ostrove JM, Inchauspe G et al. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med 1988; 108:221–237.

    PubMed  CAS  Google Scholar 

  7. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Int Med 1995; 155:1605–1609.

    Article  CAS  Google Scholar 

  8. Guess HA, Broughton DD, Melton LJ, Kurland LT. Population-based studies of varicella complications. Pediatrics 1986; 78:723–727.

    PubMed  CAS  Google Scholar 

  9. Nikkels AF, Pierard GB. Necrotizing varicella zoster virus folliculitis. Eur J Dermatol 2003; 13:587–589.

    PubMed  Google Scholar 

  10. Frangides CY, Pneumatikos I. Varicellazoster virus pneumonia in adults: report of 14 cases and review of the literature. Eur J Intern Med 2004; 15:364–370.

    Article  PubMed  Google Scholar 

  11. Snoeck R, De Clercq E. Herpesvirus infections in immunocompromised patients. In: Klastersky J, ed. Infectious complications of cancer. Boston: Kluwer Academic Publishers; 1995: 149–71.

    Google Scholar 

  12. Thomson KJ, Hart DP, Banerjee L et al. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogenic haemopoietic stem cell transplantation. Bone Marrow Trans 2005; 35:1065–1069.

    Article  CAS  Google Scholar 

  13. Mofenson LM, Oleske J, Serchuck L et al. Treating opportunistic infection among HIV-exposed and infected children: recommendations from CDC, the National Institute of Health, and the Infectious Diseases Society of America. Clin Infect Dis 2005; 40:S1–84.

    Article  PubMed  Google Scholar 

  14. Kellner B, Kitai L, Krafchik B. What syndrome is this ? Pediatr Dermatol 1996; 13:341–344.

    Article  PubMed  CAS  Google Scholar 

  15. Chidiac C, Bruxelle J, Daurès J et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001; 33:62–69.

    Article  PubMed  CAS  Google Scholar 

  16. Liesegang TJ. Varicella zoster viral disease. Mayo Clin Proc 1999; 74:983–988.

    Article  PubMed  CAS  Google Scholar 

  17. Furuta Y, Ohtani F, Aizawa H et al. Varicellazoster virus reactivation is an important cause of acute peripheral facial paralysis in children. Pediatr Infect Dis J 2005; 24:97–101.

    Article  PubMed  Google Scholar 

  18. Glesby MY, Moore RD, Chaisson RE. Clinical spectrum of herpes zoster in adults infected with HIV. Clin Infect Dis 1995; 21:370–375.

    PubMed  CAS  Google Scholar 

  19. Pope JE, Krizova A, Ouimet JM et al. Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or non-inflammatory musculo-skeletal disorders. J Rheumatol 2004; 31:274–279.

    PubMed  Google Scholar 

  20. Toney JF. Skin manifestations of herpesvirus infections. Curr Infect Dis Rep 2005; 7:359–364.

    Article  PubMed  Google Scholar 

  21. Huraux JM. Généralités sur les Herpesviridae. In: Huraux JM, Nicolas JC, Agut H, Peigue-Lafeuille H, eds. Virologie médicale. Paris: Estem; 2003. p. 153–159.

    Google Scholar 

  22. Laurent R. Herpès. Encycl Med Chir (Elsevier SAS, Paris), Dermatologie, 98-290-A-10, 2002. 11 p.

    Google Scholar 

  23. Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet 2001; 357:1513–1518.

    Article  PubMed  CAS  Google Scholar 

  24. Rozenberg F. Physiopathologie de l’infection à virus herpès simplex. Virologie 2000; 4 (n o spécial):7–14.

    Google Scholar 

  25. Snoeck R, De Clercq E. Herpes virus infection in immunocompromised patients. In: Klastersky J, ed. Infections complication of cancer. Amsterdam: Kluwer Academic Publishers; 1995: 149–171.

    Google Scholar 

  26. Martin L. Herpès orofacial, autres localisations herpétiques. Ann Dermatol Venereol 2002; 129:494–506.

    PubMed  CAS  Google Scholar 

  27. Cherpes TL, Meyn LA, Hillier SL. Cunnilingus and vaginal intercourse are risk factors for herpes simplex virus type 1 acquisition in women. Sex Transm Dis 2005; 32:84–89.

    Article  PubMed  Google Scholar 

  28. Malkin JE, Morand P, Malvy D et al. Seroprevalence of HSV1 and HSV2 infections in the general French population. Sex Transm Infect 2002; 78:201–203.

    Article  PubMed  CAS  Google Scholar 

  29. Mertz G, Benedetti JK, Ashley R et al. Risk factors for the sexual transmission of génital herpes. Ann Intern Med 1992; 116:197–202.

    PubMed  CAS  Google Scholar 

  30. Halioua B, Malkin JB. Epidemiology of genital herpes: recent advances. Eur J Dermatol 1999; 9:177–184.

    PubMed  CAS  Google Scholar 

  31. Corey L. The current trend in genital herpes: progress in prevention. Sex Transm Dis 1994; 21(suppl. 1):538–544.

    Google Scholar 

  32. Christenson B, Bottinger M, Swensson A et al. A 15-year surveillance study of antibodies to herpes simplex virus type 1 and 2 in a cohort of young girls. J Infect Dis 1992; 25:147–154.

    CAS  Google Scholar 

  33. Ashley R. Laboratory techniques in the diagnosis of herpes simplex infection. Genitourin Med 1993; 64:174–183.

    Google Scholar 

  34. Pedoby RG, Andrews N, Brown D et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 2004; 80:185–191.

    Article  Google Scholar 

  35. Lecat M. Herpès cutanéo-muqueux chez l’immunocompétent et grossesse. Ann Dermatol Venereol 2002; 129:523–532.

    PubMed  CAS  Google Scholar 

  36. Janier M, Lassau F, Bloch J et al. Seroprevalence of herpes simplex virus type 2 antibodies in an STD clinic in Paris. Int J STD AIDS 1999; 10:522–526.

    Article  PubMed  CAS  Google Scholar 

  37. Wald A, Zeh J, Secke S et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342:844–845.

    Article  PubMed  CAS  Google Scholar 

  38. Brown ZA. Genital herpes complicating pregnancy. Dermatol Clin 1998; 16:805–810.

    Article  PubMed  CAS  Google Scholar 

  39. Fonnest G, De La Fuente Fonnest I, Weber T. Neonatal herpes in Denmark: 1977–1991. Acta Obstet Gynecol Scand 1997; 76:355–358.

    PubMed  CAS  Google Scholar 

  40. Berrebi A, Thene M, Nowakowska D. Herpès et grossesse. Rev Prat Gynecol Obstet 2000; 44:25–28.

    Google Scholar 

  41. Huraux JM, Huraux-Rendu C, Blanchier H et al. Herpès génital et grossesse: des mesures essentiellement préventives. Rev Prat 1994; 44:499–503.

    PubMed  CAS  Google Scholar 

  42. Huraux JM. Épidémiologie des infections à herpes simplex virus chez la femme enceinte et l’enfant et transmission materno-fœtale. Presse Med 1995; 24(suppl. 25):2–3.

    Google Scholar 

  43. Berland M. Herpès génital et accouchement. Rev Fr Gynecol Obstet 1991; 86:639–643.

    PubMed  CAS  Google Scholar 

  44. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing World. Herpes 2004; 11(suppl. 1):14A–35A.

    Google Scholar 

  45. O’_Farrel N, Tovey SJ. High cumulative incidence of genital herpes amongst HIV-1 seropositive heterosexuals in south London. Int J STD AIDS 1994; 5:415–418.

    Google Scholar 

  46. Freedman E, Mindel A. Epidemiology of herpes and HIV co-infection. J HIV Ther 2004; 9:4–8.

    PubMed  Google Scholar 

  47. Heng MC, Heng SY, Allen SG. Co-infection and synergy of HIV-1 and HSV-1. Lancet 1994; 343:255–258.

    Article  PubMed  CAS  Google Scholar 

  48. Schacker T. The role of HSV in the transmission and progression of HIV. Herpes 2001; 8:46–49.

    PubMed  CAS  Google Scholar 

  49. Suligoi B, Dorrucci M, Volpi A et al. Italian seroconversion study. Absence of an effect of herpes simplex virus type 2 infection on HIV disease progression: data from a cohort of HIV-positive individuals with known date of seroconversion. AIDS 2001; 15:133–135.

    Article  PubMed  CAS  Google Scholar 

  50. Caumes E. Herpès non génital de l’adulte: clinique, valeur diagnostique de la clinique, évolution. Ann Dermatol Venereol 2002; 129:547–602.

    Google Scholar 

  51. Yeung-Yue KA, Brentjens MH, Lee PC, Tyring SK. Herpes simplex viruses 1 and 2. Dermatol Clin 2002; 20:249–266.

    Article  PubMed  Google Scholar 

  52. Gill MJ, Arlette J, Buchan KA. Herpes simplex virus infection of the hand. J Am Acad Dermatol 1990; 22:111–116.

    Article  PubMed  CAS  Google Scholar 

  53. Toney JF. Skin manifestations of herpes virus infection. Curr Infect Dis Rep 2005; 7:354–364.

    Article  Google Scholar 

  54. Colin J. Les kératites herpétiques. Infect Immun 1994; 1:158–164.

    Google Scholar 

  55. Bossi P. Herpès génital: épidémiologie, modes de transmission, clinique, excrétion virale asymptomatique, conséquences sur les autres maladies sexuellement transmissibles, traitement et prévention. Ann Dermatol Venereol 2002; 129:477–493.

    PubMed  CAS  Google Scholar 

  56. Janier M. Herpès des organes génitaux externes en dehors de la grossesse. Ann Dermatol Venereol 2002; 129:586–596.

    PubMed  CAS  Google Scholar 

  57. Murakami S, Mizobuchi M, Nakashiro Y et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996; 124:27–30.

    PubMed  CAS  Google Scholar 

  58. Huraux JM, Rosenberg F. Herpes simplex virus. In: Huraux JM, Nicolas JC, Agut H, Peigue-Lafeuille H, éd. Virologie médicale. Paris: Estem; 2003: 161–177.

    Google Scholar 

  59. Devergie A. Chimiothérapie antivirale de l’herpès des greffés de moelle osseuse. Virologie 2000; 4:39–41.

    Google Scholar 

  60. Aurelian L, Koluba H, Burnett JW. Understanding the pathogenesis of HSV-associated erythema multiformis. Dermatology 1998; 197:219–222.

    Article  PubMed  CAS  Google Scholar 

  61. Kimberlin DW. Advances in the treatment of neonatal herpes simplex virus infections. Rev Med Virol 2001; 11:157–163.

    Article  PubMed  CAS  Google Scholar 

  62. Conférence de consensus: prise en charge de l’herpès cutanéo-muqueux chez l’immunocompétent, manifestations oculaires exclues. Ann Dermatol Venereol 2002; 129:667–679.

    Google Scholar 

  63. Wald A, Zeh J, Barnum G et al. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996; 124:8–15.

    PubMed  CAS  Google Scholar 

  64. Sacks SL, Griffiths PD, Corey L et al. HSV shedding. Antiviral Res 2004; 63(suppl. 1):S19–26.

    Article  PubMed  CAS  Google Scholar 

  65. Braig S, Luton D, Sibony O et al. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and virus shedding. Eur J Obstet Gynecol Reprod Biol 2001; 96:55–58.

    Article  PubMed  CAS  Google Scholar 

  66. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1964; 15:702–703.

    Article  Google Scholar 

  67. Nicolas JC, Meyohas MC. Virus Epstein-Barr. In: Huraux JM, Nicolas JC, Agut H, Peigue-Lafeuille H, ed. Virologie médicale. Paris: Estem; 2003. p. 213–227.

    Google Scholar 

  68. Aractingi S, Fermand JP, Morinet F. Infections à virus d’Epstein-Barr et pathologie cutanée. In: Chosidow O, ed. Virus et peau. Paris: Estem; 1994. p. 105–109.

    Google Scholar 

  69. Toney JF. Skin manifestations of herpes virus infections. Curr Infect Dis Rep 2005; 7:354–364.

    Article  Google Scholar 

  70. Hofmann B, Schuppe HC, Adams O et al. Gianotti-Crosti syndrome associated with Epstein-Barr virus infection. Pediatr Dermatol 1997; 14:273–277.

    Article  PubMed  CAS  Google Scholar 

  71. Hsiah MY, Huang PH. The juvenile variant of papular-purpuric gloves and socks syndrome and its association with viral infection. Br J Dermatol 2004; 151:201–206.

    Article  Google Scholar 

  72. Taylor S, Drake SM, Dedicoat M, Wood MJ. Genital ulcers associated with acute Epstein-Barr virus infection. Sex Transm Infect 1998; 74:296–297.

    Article  PubMed  CAS  Google Scholar 

  73. Pelletier F, Leblanc L, Estavoyer JM et al. Ulcère de Lipschütz au cours d’une primoinfection à virus Epstein-Barr. Ann Dermatol Venereol 2002; 129:905–907.

    PubMed  CAS  Google Scholar 

  74. Pelletier F, Aubin F, Puzenat E et al. Lipschütz genital ulceration: a rare manifestation of parathyroid fever. Eur J Dermatol 2003; 13:297–298.

    PubMed  Google Scholar 

  75. Laurent R, Drobacheff C. Manifestations dermatologiques de l’infection VIH et du SIDA. In: Bessis D, Guilhou JJ, éd. La pathologie dermatologique en médecine interne. Paris: Arnette; 1999. p. 533–546.

    Google Scholar 

  76. Itin P, Rufli T, Rüdlinger R et al. Oral hairy leukoplasia in a HIV-negative renal transplant patient. Dermatologica 1988; 177:126–128.

    Article  PubMed  CAS  Google Scholar 

  77. Corso B, Eversole LR, Hutt-Fletchner L. Hairy leukoplasia: EBV receptor on oral keratinocyte plasma membranes. Oral Surg Oral Med Oral Pathol 1989; 67:416–421.

    Article  PubMed  CAS  Google Scholar 

  78. Kano Y, Shidhara T. Current understanding of cytomegalovirus infection in immunocompetent individuals. J Dermatol Sci 2000; 22:196–204.

    Article  PubMed  CAS  Google Scholar 

  79. Snoeck R, De Clercq E. Herpes-virus infection in immunocompromised patients. In: Klastersky J, ed. Infectious complications of cancer. Boston: Kluwer Academic Publishers; 1995: 149–171.

    Google Scholar 

  80. Alain S, Mazeron MC. Cytomegalovirus. In: Huraux JM, Nicolas JC, Agut H, Peigue-Lafeuille H, ed. Virologie médicale. Paris: Estem; 2003. p. 195–211.

    Google Scholar 

  81. Britt WJ, Alford CA. Cytomegalovirus. In: Fields BN, Knipe DM, Howley PM, eds. Virology. 3e éd. Philadelphia: Lippincott-Raven; 1996. p. 2493–2523.

    Google Scholar 

  82. Drago F, Aragone MG, Lugani C, Rebora A. Cytomegalovirus infections in normal and immunocompromised humans. Dermatology 2000; 200:189–195.

    Article  PubMed  CAS  Google Scholar 

  83. Bournerias I, Boisnic S. Cytomegalovirus. In: Chosidow O, ed. Virus et peau. Paris: Estem; 1994. p. 115–121.

    Google Scholar 

  84. Klemola E. Hypersensitivity reaction to ampicillin in cytomegalovirus mononucleosis. Scand J Infect Dis 1970; 2:29.

    PubMed  CAS  Google Scholar 

  85. Nico MMS, Cymbalista NC, Hurtado YCP, Borges LHB. Perianal cytomegalovirus ulcer in an HIV infected patient: case report and review of literature. J Dermatol 2000; 27:99–105.

    PubMed  CAS  Google Scholar 

  86. Weigand DA, Burgdorf WHC, Tarpay MM. Vasculitis in cytomegalovirus infection. Arch Dermatol 1980; 116:1174–1176.

    Article  PubMed  CAS  Google Scholar 

  87. Qazi NA, Morlese JF, Walsh JC et al. Case report: severe cutaneous ulceration secondary to cytomegalovirus inclusion disease during successful immune reconstitution with HAART. AIDS Read 2002; 12:452–454; 456–457.

    PubMed  Google Scholar 

  88. Dauden E, Fernandez-Buezo G, Fraga J et al. Mucocutaneous presence of cytomegalovirus associated with immunodeficiency virus infection: discussion regarding its pathogenic role. Arch Dermatol 2001; 137:443–448.

    PubMed  CAS  Google Scholar 

  89. Seishima M, Oyama Z, Yamamura M. Erythema multiforme associated with cytomegalovirus infection in non-immunosuppressed patients. Dermatology 2001; 203:299–302.

    Article  PubMed  CAS  Google Scholar 

  90. Oskay T, Karademir A, Kutluay L. Vesicular and pustular eruption related to cytomegalovirus in an immunocompetent patient. Clin Exp Dermatol 2003; 28:610–612.

    Article  PubMed  CAS  Google Scholar 

  91. Kuroda K, Yabunami H, Hisanaga Y. Acute hemorrhagic oedema of infancy associatedwith cytomegalovirus infection. Br J Dermatol 2002; 147:1254–1257.

    Article  PubMed  CAS  Google Scholar 

  92. Casals DS, Nunes Ede A, Maruta CW et al. Disseminated cytomegalovirus disease as a cause of prolonged fever in a bullous pemphigoid patient under systemic steroid therapy. J Dermatol 2003; 30:332–336.

    PubMed  Google Scholar 

  93. Toome BK, Bowers KE, Scott GA. Diagnosis of cutaneous cytomegalovirus infection: a review and report of a case. J Am Acad Dermatol 1991; 24:857–863.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Laurent, R. (2008). Infections à Herpesviridae. In: Manifestations dermatologiques des maladies infectieuses, métaboliques et toxiques. Springer, Paris. https://doi.org/10.1007/978-2-287-48494-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-48494-0_10

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-48493-3

  • Online ISBN: 978-2-287-48494-0

Publish with us

Policies and ethics